Creatine and Creatinine Metabolism - Physiological Reviews

1186 MARKUS WYSS AND RIMA KADDURAH-DAOUK Volume 80
CLARK JB, AND HEALES SJR. Nitric oxide-mediated mitochondrial
damage in the brain: mechanisms and implications for neurodegenerative
diseases. J Neurochem 68: 2227–2240, 1997.
77. BONAS JE, COHEN BD, AND NATELSON S. Separation and estimation
of certain guanidino compounds. Application to human
urine. Microchem J 7: 63–77, 1963.
78. BONDAVALLI F, BRUNO O, RANISE A, SCHENONE P, D’AMICO
M, PARRILLO C, FILIPPELLI W, AND ROSSI F. 3,5-Diphenyl-1Hpyrazole
derivatives. 2-Substituted 4-phenyl-5-(3,5-diphenyl-1Hpyrazol-1-yl)
pyrimidines with platelet antiaggregating and other
activities. Farmaco 47: 171–190, 1992.
79. BONSETT CA AND RUDMAN A. The dystrophin connection–ATP?
Med Hypotheses 38: 139–154, 1992.
80. BONVICINI P, CERIOTTI G, AND DE’BESI T. Kinetic enzymatic
determination of creatinine by a rapid semiautomated procedure.
J Clin Chem Clin Biochem 20: 185–189, 1982.
81. BOOBIS AR, LYNCH AM, MURRAY S, DE LA TORRE R, SOLANS
A, FARRÉ M, SEGURA J, GOODERHAM NJ, AND DAVIES DS.
CYP1A2-catalyzed conversion of dietary heterocyclic amines to
their proximate carcinogens is their major route of metabolism in
humans. Cancer Res 54: 89–94, 1994.
82. BOOTH FW AND THOMASON DB. Molecular and cellular adaptation
of muscle in response to exercise: perspectives of various
models. Physiol Rev 71: 541–585, 1991.
83. BOROUJERDI M AND MATTOCKS AM. Metabolism of creatinine
in vivo. Clin Chem 29: 1363–1366, 1983.
84. BOSCO C, TIHANYI J, PUCSPK J, KOVACS I, GABOSSY A, COLLI
R, PULVIRENTI G, TRANQUILLI C, FOTI C, VIRU M, AND VIRU A.
Effect of oral creatine supplementation on jumping and running
performance. Int J Sports Med 18: 369–372, 1997.
85. BOTTOMLEY PA, COUSINS JP, PENDREY DL, WAGLE WA,
HARDY CJ, EAMES FA, MACCAFFREY RJ, AND THOMPSON DA.
Alzheimer dementia: quantification of energy metabolism and mobile
phosphoesters with P-31 NMR spectroscopy. Radiology 183:
695–699, 1992.
86. BOTTOMLEY PA, HARDY CJ, COUSINS JP, ARMSTRONG M, AND
WAGLE WA. AIDS dementia complex: brain high-energy phosphate
metabolite deficits. Radiology 176: 407–411, 1990.
87. BOTTOMLEY PA AND WEISS RG. Non-invasive magnetic-resonance
detection of creatine depletion in non-viable infarcted myocardium.
Lancet 351: 714–718, 1998.
88. BOURDAKOS N AND WOLF S. Creatine and muscular dystrophy.
Arch Neurol 6: 439–450, 1962.
89. BOUZIDI MF, ENJOLRAS N, CARRIER H, VIAL C, LOPEZ-ME-
DIAVILLA C, BURT-PICHAT B, COUTHON F, AND GODINOT C.
Variations of muscle mitochondrial creatine kinase activity in
mitochondrial diseases. Biochim Biophys Acta 1316: 61–70, 1996.
90. BRADAMANTE S, MONTI E, PARACCHINI L, LAZZARINI E, AND
PICCININI F. Protective activity of the spin trap tert-butyl-�phenyl
nitrone (PBN) in reperfused rat heart. J Mol Cell Cardiol
24: 375–386, 1992.
91. BRANDEJS-BARRY Y AND KORECKY B. Hemodynamic performance
of creatine-depleted rat heart in isolated blood-perfused
working preparation. In: Developments in Cardiovascular Medicine.
Symposium on Heart Function and Metabolism, edited by
N. S. Dhalla. The Hague: Nijhoff, 1987, p. 407–425.
92. BRANNON TA, ADAMS GR, CONNIFF CL, AND BALDWIN KM.
Effects of creatine loading and training on running performance
and biochemical properties of rat skeletal muscle. Med Sci Sports
Exercise 29: 489–495, 1997.
93. BRAUTBAR N. Skeletal myopathy in uremia: abnormal energy
metabolism. Kidney Int 24 Suppl 16: S81–S86, 1983.
94. BRDICZKA D AND WALLIMANN T. The importance of the outer
mitochondrial compartment in regulation of energy metabolism.
Mol Cell Biochem 133: 69–83, 1994.
95. BRODY LC, MITCHELL GA, OBIE C, MICHAUD J, STEEL G,
FONTAINE G, ROBERT M-F, SIPILÄ I, KAISER-KUPFER M, AND
VALLE D. Ornithine �-aminotransferase mutations in gyrate atrophy.
Allelic heterogeneity and functional consequences. J Biol
Chem 267: 3302–3307, 1992.
96. BROSNAN MJ, CHEN L, WHEELER CE, VAN DYKE TA, AND
KORETSKY AP. Phosphocreatine protects ATP from a fructose
load in transgenic mouse liver expressing creatine kinase. Am J
Physiol Cell Physiol 260: C1191–C1200, 1991.
97. BROSNAN MJ, HALOW JM, AND KORETSKY AP. Manipulating
creatine kinase activity in transgenic mice to study control of
energy metabolism. Biochem Soc Trans 19: 1010–1014, 1991.
98. BROWN GG, LEVINE SR, GORELL JM, PETTEGREW JW,
GDOWSKI JW, BUERI JA, HALPERN JA, AND WELCH KMA. In
vivo 31 P NMR profiles of Alzheimer’s disease and multiple subcortical
infarct dementia. Neurology 39: 1423–1427, 1989.
99. BROYER M, DELAPORTE C, AND MAZIERE B. Water, electrolytes
and protein content of muscle obtained by needle biopsy in uremic
children. Biomedicine 21: 278–285, 1974.
100. BRUHN H, FRAHM J, MERBOLDT KD, HÄNICKE W, HANEFELD
F, CHRISTEN HJ, KRUSE B, AND BAUER HJ. Multiple sclerosis in
children: cerebral metabolic alterations monitored by localized
proton magnetic resonance spectroscopy in vivo. Ann Neurol 32:
140–150, 1992.
101. BRUNNER HG, KORNELUK RG, COERWINKEL-DRIESSEN M,
MACKENZIE A, SMEETS H, LAMBERMON HMM, VAN OOST BA,
WIERINGA B, AND ROPERS H-H. Myotonic dystrophy is closely
linked to the gene for muscle-type creatine kinase (CKMM). Hum
Genet 81: 308–310, 1989.
102. BURBAEVA GS, AKSENOVA MV, AND BIBIKOVA VI. The activity
of CK BB in certain brain structures of schizophrenic patients and
normal controls. Zur Neiropatol Psichiatr 87: 1024–1028, 1987.
103. BURKE LM, PYNE DB, AND TELFORD RD. Effect of oral creatine
supplementation on single-effort sprint performance in elite
swimmers. Int J Sport Nutr 6: 222–233, 1996.
104. BUSER PT, WAGNER S, WU ST, DERUGIN N, PARMLEY WW,
HIGGINS CB, AND WIKMAN-COFFELT J. Verapamil preserves
myocardial performance and energy metabolism in left ventricular
hypertrophy following ischemia and reperfusion. Phosphorus
31 magnetic resonance spectroscopy study. Circulation 80: 1837–
1845, 1989.
105. CADOUX-HUDSON TA, BLACKLEDGE MJ, AND RADDA GK. Imaging
of human brain creatine kinase activity in vivo. FASEB J 3:
2660–2666, 1989.
106. CADOUX-HUDSON TAD, KERMODE A, RAJAGOPALAN B, TAY-
LOR D, THOMPSON AJ, ORMEROD IEC, MCDONALD WI, AND
RADDA GK. Biochemical changes within a multiple sclerosis
plaque in vivo. J Neurol Neurosurg Psychiatry 54: 1004–1006,
1991.
107. CAMACHO SA, WIKMAN-COFFELT J, WU ST, WATTERS TA,
BOTVINICK EH, SIEVERS R, JAMES TL, JASMIN G, AND PARM-
LEY WW. Improvement in myocardial performance without a
decrease in high-energy phosphate metabolites after isoproterenol
in Syrian cardiomyopathic hamsters. Circulation 77: 712–719,
1988.
108. CAREGARO L, MENON F, ANGELI P, AMODIO P, MERKEL C,
BORTOLUZZI A, ALBERINO F, AND GATTA A. Limitations of
serum creatinine level and creatinine clearance as filtration markers
in cirrhosis. Arch Intern Med 154: 201–205, 1994.
109. CARLSON M AND VAN PILSUM JF. S-adenosylmethionine: guanidinoacetate
N-methyltransferase activities in livers from rats
with hormonal deficiencies or excesses. Proc Soc Exp Biol Med
143: 1256–1259, 1973.
110. CARMICHAEL PL, STONE EM, GROVER PL, GUSTERSON BA,
AND PHILLIPS DH. Metabolic activation and DNA binding of food
mutagens and other environmental carcinogens in human mammary
epithelial cells. Carcinogenesis 17: 1769–1772, 1996.
111. CARTER AJ AND MÜLLER RE. Application and validation of an
ion-exchange high-performance liquid chromatographic method
for measuring adenine nucleotides, creatine and creatine phosphate
in mouse brain. J Chromatogr 527: 31–39, 1990.
112. CARTER AJ, MÜLLER RE, PSCHORN U, AND STRANSKY W.
Preincubation with creatine enhances levels of creatine phosphate
and prevents anoxic damage in rat hippocampal slices.
J Neurochem 64: 2691–2699, 1995.
113. CASEY A, CONSTANTIN-TEODOSIU D, HOWELL S, HULTMAN
E, AND GREENHAFF PL. Creatine ingestion favorably affects performance
and muscle metabolism during maximal exercise in
humans. Am J Physiol Endocrinol Metab 271: E31–E37, 1996.
114. CHAE Y-J, CHUNG C-E, KIM B-J, LEE M-H, AND LEE H. The gene